CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 24 No. 8
INTEGRATIVE ONCOLOGY 

Saw Palmetto

Complementary Therapies, Herbs, and other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | July 22, 2010
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Saw palmetto, a small, slow-growing palm, is prevalent in the southeastern United States. Its berries are a rich source of fatty acids and phytosterols, and were used by Native Americans as food and also as medicine to treat urinary tract problems. Saw palmetto is currently used to promote urination, reduce inflammation, and to treat prostatic conditions such as benign prostatic hyperplasia (BPH) and prostate cancer. It is available in the form of dried berries, tablets, capsules, and liposterolic extracts. —Barrie Cassileth, phd

ALSO KNOWN AS: Saw, palmetto berry, American dwarf palm tree, cabbage palm.

RESEARCH: Based on its historic use and laboratory studies, the ability of saw palmetto to improve prostate health has been the subject of many clinical trials, but data are inconclusive. Some studies indicate that it improves urinary flow rate and reduces nocturia in patients with benign prostatic hyperplasia,[1,2] but other research found no such effects.[3,4] A recent study showed that saw palmetto may benefit patients with chronic bacterial prostatitis when coadministered with Urtica dioica, curcumin, and quercitin.[5] Further re-search is needed to resolve the ambiguity.

Saw palmetto demonstrated anticancer effects in vitro and in animal studies.[6] It also was shown to increase the radiosensitivity of normal prostate cells; interestingly, cancerous cells remained unaffected.[7]

ADVERSE REACTIONS: Although infrequent, saw palmetto may cause nausea, vomiting, gastrointestinal problems, and diarrhea.[8]

A case of severe intraoperative hemorrhage following consumption of saw palmetto has been reported.[8]

Hematuria and coagulopathy were observed in a patient with use of saw palmetto.[9]

HERB-DRUG INTERACTIONS: Anticoagulants: Saw palmetto may have additive anticoagulant effects and can prolong bleeding time.[8]

COMMENTS: The berries of saw palmetto or dwarf palm, native to the southeastern United States, were used by Native Americans as food and as a remedy for urinary tract problems. Today, saw palmetto is extremely popular in both the US and Europe for the treatment of symptoms associated with benign prostatic hyperplasia.

Saw palmetto has been investigated by many groups, but evidence of its efficacy for the treatment of prostatic conditions is mixed. Additional research is needed.

Preclinical data indicate that saw palmetto has anticancer properties. However, a recent study revealed an unexpected preferential increase in radiosensitivity of normal prostate cells over malignant cells in the presence of saw palmetto. Until definitive data are available, prostate cancer patients should avoid saw palmetto supplementation when undergoing radiotherapy.

TAKE HOME POINTS
• The berries of saw palmetto, rich in fatty acids and phytosterols, were used in Native American medicine for urinary tract problems.
• Current evidence for saw palmetto’s effectiveness in treating prostatic conditions is mixed.
• Because saw palmetto can increase the sensitivity of normal prostate cells to radiation, patients with prostate cancer should avoid this supplement during radiotherapy.
For additional information, visit the Memorial Sloan-Kettering Cancer Center Integrative Medicine Service website, “About Herbs,” at http://www.mskcc.org/AboutHerbs.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES

1. Shi R, Xie Q, Gang X, et al: Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: A randomized trial in Shanghai, China. J Urol 179:610-615, 2008.

2. Hizli F, Uygur MC: A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia. Int Urol Nephrol 39:879-886, 2007.

3. Bent S, Kane C, Shinohara K, et al: Saw palmetto for benign prostatic hyperplasia. N Engl J Med 354:557-566, 2006.

4. Tacklind J, MacDonald R, Rutks I, et al: Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev Apr 15(2):CD001423, 2009.

5. Cai T, Mazzoli S, Bechi A, et al: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: Results from a prospective randomised study. Int J Antimicrob Agents 33:549-553, 2009.

6. Wadsworth TL, Worstell TR, Greenberg NM, et al: Effects of dietary saw palmetto on the prostate of transgenic adenocarcinoma of the mouse prostate model (TRAMP). Prostate 67:661-673, 2007.

7. Hasan Y, Schoenherr D, Martinez AA, et al: Prostate-specific natural health products (dietary supplements) radiosensitize normal prostate cells. Int J Radiat Oncol Biol Phys 76:896-904, 2010.

8. Cheema P, El-Mefty O, Jazieh AR, et al: Intraoperative haemorrhage associated with the use of extract of saw palmetto herb: A case report and review of literature. J Intern Med 250:167-169, 2001.

9. Villanueva S, González J: Coagulopathy induced by saw palmetto: A case report. Bol Asoc Med P R 101:48-50, 2009.


 
RELATED CONTENT

The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
Cancer Quackery: The Persistent Popularity of Useless, Irrational 'Alternative' Treatments
ONCOLOGY,  August 20, 2012
Integrative Medicine: Not Just Garnish
ONCOLOGY Nurse Edition,  May 9, 2012
Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy